Cargando…
The Immune System as a Therapeutic Target for Alzheimer’s Disease
Alzheimer’s disease (AD) is a heterogeneous neurodegenerative disorder and is the most common cause of dementia. Furthermore, aging is considered the most critical risk factor for AD. However, despite the vast amount of research and resources allocated to the understanding and development of AD trea...
Autores principales: | Zieneldien, Tarek, Kim, Janice, Sawmiller, Darrell, Cao, Chuanhai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506058/ https://www.ncbi.nlm.nih.gov/pubmed/36143476 http://dx.doi.org/10.3390/life12091440 |
Ejemplares similares
-
The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment
por: Zieneldien, Tarek, et al.
Publicado: (2022) -
COVID-19 Vaccines: Current Conditions and Future Prospects
por: Zieneldien, Tarek, et al.
Publicado: (2021) -
Multi-Targeting Intranasal Nanoformulation as a Therapeutic for Alzheimer’s Disease
por: Fihurka, Oksana, et al.
Publicado: (2023) -
Therapeutic Cocktail Approach for Treatment of Hyperhomocysteinemia in
Alzheimer’s Disease
por: Leon, Michael, et al.
Publicado: (2018) -
Examining the Toxicity of α-Synuclein in Neurodegenerative Disorders
por: Shan, Frank Y., et al.
Publicado: (2021)